CRMDCorMedix Inc.

$518M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$163,692+605.3% YoY

Gross Profit

-$63,263-38.6% margin

Operating Income

-$5M-3007.6% margin

Net Income

-$5M-3157.1% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

+517.2%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$809,331

Balance Sheet

Total Assets

$27M

Total Liabilities

$11M

Stockholders' Equity

$17M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$163,692	$23,210	+605.3%
Gross Profit	-$63,263	-$5,365	-1079.2%
Operating Income	-$5M	-$10M	+51.7%
Net Income	-$5M	-$10M	+49.3%

CRMD Q1 2019 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena